$APDN Board of Directors:
Dr. James A. Hayward was appointed by the Board of Directors as President and Chairman of the Board of Directors on June 12, 2007.
Dr. Hayward has been our Chief Executive Officer since March 17, 2006, prior to which he was acting Chief Executive Officer since October 5, 2005. He has over 20 years of experience in the biotechnology, pharmaceutical, life science and consumer product industries. He was one of the founding principals and research director of Europe's first liposome company, Biocompatibles Ltd. From 1984 to 1989, he was responsible for product development at Esteé Lauder Companies, where he served as director of research worldwide.
Between 1990 and July 2004, Dr. Hayward was the Chairman, President and CEO of The Collaborative Group, Ltd., a provider of products and services to the biotechnology, pharmaceutical and consumer-product industries based in Stony Brook, New York.
Since 2000, Dr. Hayward has been a General Partner of Double D Venture Fund, a venture capital firm based in New York, New York. He also serves on the boards of the Stony Brook Foundation, the Research Foundation of the State of New York, Long Island Life Sciences Initiative and the Ward Melville Heritage Foundation.
Dr. Hayward received his bachelor's degree in Biology and Chemistry from the State University of New York at Oneonta in 1976, his Ph.D. in Molecular Biology and Biophysics from the State University of New York at Stony Brook in 1983, and an honorary Doctor of Science from Stony Brook in 2000.
Dr. Yacov Shamash has been a member of the Board of Directors since March 17, 2006.
Dr. Shamash is Vice President for Economic Development at the State University of New York at Stony Brook. Since 1992, he has been the Dean of the College of Engineering and Applied Sciences at the University, and Founder of the New York State Center for Excellence in Wireless Technologies (CEWIT) and The Advanced Energy Research & Technology Center (AERTC) at the University. Dr. Shamash developed and directed the NSF Industry/University Cooperative Research Center for the Design of Analog/Digital Integrated Circuits from 1989 to 1992 and also served as Chairman of the Electrical and Computer Engineering Department at Washington State University from 1985 until 1992. Dr. Shamash also serves on the Board of Directors of KeyTronic Corp., American Medical Alert Corp., and Softheon Corporation.
Sanford R. Simon - Director
Dr. Sanford R. Simon has been a member of the board of directors since March 17, 2006.
Dr. Simon has been a Professor of Biochemistry, Cell Biology and Pathology at Stony Brook since 1997. He joined the faculty at Stony Brook as an Assistant Professor in 1969 and was promoted to Associate Professor with tenure in 1975. Dr. Simon was a member of the Board of Directors of The Collaborative Group from 1995 to 2004. From 1967 to 1969 Dr. Simon was a Guest Investigator at Rockefeller University.
Dr. Simon received a B.A. in Zoology and Chemistry from Columbia University in 1963, a Ph.D. in Biochemistry from Rockefeller University in 1967, and studied as a postdoctoral fellow with Nobel Prize winner Max Perutz in Cambridge, England.
Ming-Hwa Benjamin Liang has been our Secretary and Strategic Technology Development Officer since October 2005.
Between May 1999 and September 2005, Mr. Liang was the director of research and development at Biowell Technology Inc. He currently holds the position Corporate Secretary and Strategic Technology Development Officer at Applied DNA Sciences.
Mr. Liang received his B.S. in Bio-Agriculture from Colorado State University in 1989, a M.S. in Horticulture from the University of Missouri at Columbia in 1991, his Ph.D. in Plant Science from the University of Missouri at Columbia in 1997 and his LL.M. in Intellectual Property Law from Shih Hsin University, Taiwan in 2004.
Dr. Charles Ryan joined the Board of Directors on August 10, 2011.
Dr. Ryan is the Sr. Vice President, and Chief Intellectual Property Counsel at Forest Laboratories, where he has been employed since 2003. Forest, with a market capitalization of nearly $10 billion, develops branded drugs, including Lexapro and Celexa, used to treat depression, Benicar, for hypertension and Aerobid, a metered dose inhaler for asthma.
Dr. Ryan earned a doctorate in oral biology and pathology from SUNY Stony Brook and a law degree from Western New England College School of Law.
Karol Gray joined the Board of Directors on August 10, 2011.
In December 2011, Ms. Gray assumed the position of Vice President for Finance and Administration at UNC-Chapel Hill. Ms. Gray previously was the Vice President for Finance and Administration and the Chief Financial Officer at the University at Stony Brook. She is active on several committees, including the Brookhaven National Laboratory Audit Committee, the Presidential Budget Working Group, and the Investment Subcommittee of the Research Foundation of the State University of New York, and is a member of the Executive Committee of the State University of New York Business and Officers Association.
Ms. Gray is a Certified Public Accountant with a Bachelor in Business Administration from Hofstra University.
John Bitzer joined the Board of Directors on August 10, 2011.
Mr. Bitzer is President & Chief Executive Officer of ABARTA, Inc., a private, fourth-generation family holding-company with operations in the soft drink beverages, newspaper publishing, oil and gas exploration and development, and frozen food industries. In 1985, Mr. Bitzer began his career in sales for the Cleveland Coca-Cola Bottling Company. He has been Publisher of Atlantic City Magazine in Atlantic City, N.J. In 1994 he founded the ABARTA Media Group and held the position of Group Publisher. In 1997 he was named President & Chief Operating Officer of ABARTA, Inc. and has been President & Chief Executive Officer since 1999. He is a director of the Institute for Entrepreneurial Excellence at the University of Pittsburgh.
Mr. Bitzer has a degree from the University of Southern California and an MBA from the University of Michigan.
Gerald Catenacci joined the Board of Directors on August 10, 2011.
Mr. Catenacci is the Founder and President of Neustrada Capital, LLC, a private investment fund. Mr. Catenacci obtained a Bachelor of Science in Civil Engineering from McMaster University in 1985, and has spent his career in equity management. Mr. Catenacci was the Founding Partner and Managing Director Principled Capital Management, a successful hedge fund that operated in New York City from 1998 to 2010.